IntegrateRNA Broadens Therapeutic Oligonucleotide Offering with Custom 2'-O-hexadecyl (C16)-siRNA Conjugates
As a leading provider of therapeutic oligonucleotides, IntegrateRNA is proud to offer a comprehensive range of custom synthesis and manufacturing services to support the development of novel nucleic acid-based therapeutics. With a focus on innovation and cutting-edge technology, IntegrateRNA is dedicated to helping researchers and pharmaceutical companies bring their therapeutics from concept to reality.
View full press release